Menu

News & Awards

Stay up to date with the latest news, awards, and achievements from CanRIO and our members.

New Article Alert! Acrocyanosis after Immunotherapy: A CanRIO Case Series

A new article published by CanRIO members in the Journal of Rheumatology (April 2025) describes 8 new cases of acral digital ischemia associated with ICI. See link for details: https://www.jrheum.org/

Read more →

New Article Alert! Chronicity of ICI-related Inflammatory Arthritis

A new article published by CanRIO members in ACR Open Rheumatology (February 18, 2025) suggests that ICI related inflammatory arthritis (IA) frequently persists after ICI discontinuation. Chronic ICI-

Read more →

CanRIO Researcher Awarded an Arthritis Society of Canada Grant!

Congratulations to Dr. Marie Hudson who has been awarded a Arthritis Society of Canada grant to study the mechanisms underlying rheumatic immune related adverse events! Using a large bank of tissue sa

Read more →

CanRIO Researchers Awarded a 2023 CIORA Grant!

Congratulations to Dr. Shahin Jamal and Dr. Tom Appleton on receiving a Canadian Initiative for Outcomes in Rheumatology cAre (CIORA) grant from the Canadian Rheumatology Association Foundation (CRAF)

Read more →

Introducing our CanRIO Twitter account!

We are pleased to share our new Twitter account! @CanRIO_Tweets Keep connected and updated with news, research, initiatives, and collaborations! Check out the link below. https://twitter.com/CanRIO_Tw

Read more →

Welcome to CanRIO.ca

CanRIO is thrilled to launch the first educational website dedicated to the rheumatic complications of immunotherapy. We hope that this website will serve as an educational resource to rheumatologists

Read more →

Hot off the Press!

CanRIO has just published its second national case series. This retrospective cohort study included 27 patients with pre-existing autoimmune disease (PAD) treated with immunotherapy. Consistent with p

Read more →

Stay Updated

Subscribe to our mailing list to receive news updates, publication announcements, and information about upcoming learning rounds.

Join Our Mailing List